Preventing intoxication


Finland, Finland

Short Summary

Catapult Cat has developed a food supplement product to prevent the symptoms of intoxication caused by alcohol. We have obtained historic scientific proof, three international patents pending and already started business in China.


Investment Raised
Previous Rounds N/A
Stage Achieving Sales
Investor Role Monthly Involvement


  • Revolutionary food supplement product for adverse effects of alcohol use
  • Scientifically tested and proven product
  • Three international patents pending
  • China operations already started
  • Huge global market potential
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

3% raised


location_on Sweden, Sweden

Innovosens is developing SMASH. SMASH, the first non-invasive, multiparametric wearable Sweat sensor for continuous monitoring of glucose and lactate levels.

€ 3,000,000


€ 50,000

Min per Investor

Global Pro
20% raised

Mobileapplication family

location_on Finland, Finland

ClickCall Ltd ( ly 3099597-7) is developing the mobileapplications family to Google Android and iPhones looking for 0,1-0,2 Me fund to us for getting ready our applications to the market at the end of 2020.

€ 500,000


€ 50,000

Min per Investor

Global Pro
35% raised

One Touch Telehealth

location_on South West, USA

We empower healthcare organizations to have their own branded video telehealth platform in minutes. Think of the text chat you see on the bottom of websites. We're that, but for telehealth. The only 100% browser-based solution in the US.

€ 460,000


€ 9,200

Min per Investor

load one similar proposal